Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity.
about
Angiotensin II Type-2 receptors modulate inflammation through signal transducer and activator of transcription proteins 3 phosphorylation and TNFα production.Angiotensin receptor blockade with candesartan attenuates atherosclerosis, plaque disruption, and macrophage accumulation within the plaque in a rabbit modelPathogenesis of deep white matter medullary infarcts: a diffusion weighted magnetic resonance imaging study.Sex differences in inflammation during atherosclerosis.Infiltration of inflammatory cells plays an important role in matrix metalloproteinase expression and activation in the heart during sepsis.The Augmenting Effects of Desolvation and Conformational Energy Terms on the Predictions of Docking Programs against mPGES-1.Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases.Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapyMatrix metalloproteinases and diabetic vascular complications.Pharmacological modulation of plaque instability.Is atrial fibrillation an inflammatory disorder?Position of fixed-dose combinations containing an AT(1)-receptor blocker and a thiazide diuretic.Role of angiotensin II receptor blockers in atherosclerotic plaque stability.Role of COX-2-derived PGE2 on vascular stiffness and function in hypertension.Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors.Cyclooxygenase products and atherosclerosisThe frail renin-angiotensin system.Matrix metalloproteinases: drug targets for myocardial infarction.Targets of chymase inhibitors.Anti-inflammatory strategies for plaque stabilization after acute coronary syndromes.Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis.Gαq G proteins modulate MMP-9 gelatinase during remodeling of the murine femoral artery.Assessment of MMP-9, TIMP-1, and COX-2 in normal tissue and in advanced symptomatic and asymptomatic carotid plaques.Olmesartan, a novel AT1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure.Clustering of risk factors increases the incidence of echolucent carotid plaque in stroke patients.A Novel Role of Irbesartan in Gastroprotection against Indomethacin-Induced Gastric Injury in Rats: Targeting DDAH/ADMA and EGFR/ERK Signaling.Oxidative stress and heart failure in altered thyroid States
P2860
Q30426697-92E4D05A-A4A6-452D-81B5-CF07ED030A5DQ34003703-9EF9899F-234F-4791-8C6C-E2DDD460AD6DQ35485645-71F5E239-80BC-4CA7-8F96-69DC27C39118Q35509492-FC3AB5C1-2C2C-457B-8C6C-7EFBE8CD479FQ35607377-83E4415F-CFFD-47F5-8734-EECCFEAC8D83Q35754939-F68C255C-DE95-479E-88DE-12FDEC19A1EAQ35911136-44796176-8A49-4CAA-AABC-E0A0BACFE9DBQ36013124-0192D0F7-D0A5-4B1C-91F6-5A9C49CFF22AQ36081593-5F15C255-88B9-42E2-841D-D4ACE60ED799Q36283516-DF9E4311-FD1C-42A0-835F-2C49446036BDQ36309624-05665634-262E-403B-8652-F53A3F274B30Q36364949-82A1D3BA-66B2-4867-B4EF-85E92FEB2E94Q36382568-A00CBCB0-F000-4A7F-9C79-130631419BE4Q36797387-223737A1-DAF8-4DA3-8E4A-0EC35CB7CE88Q36985325-E781051D-72E4-4A96-8C5C-BA32D9611EA1Q37071164-40026CD3-F445-44A0-B2B8-7D890689A8DEQ37150747-B1EC1508-BF45-41F8-82FB-66E61CF85D82Q37308645-F35CA346-3DB7-4CBC-8116-8E3DAA719310Q37835286-10D467E1-A5EE-4DE1-A14A-F77218B11179Q38103488-B74EEFA9-F517-4DB8-9449-67A5437DE785Q38317550-2CCC6D79-B5B1-44C9-9ED7-F725AF675332Q41864365-6DCB3D35-0E78-442D-8EAE-54434EC65930Q41950529-46D6B02F-B097-44AB-94C1-724FB68E99A2Q46477791-60209638-3E0F-4D38-A0E7-1509DE3CE0EDQ48449671-419BF057-1008-4F58-9ABA-CAE5B3F7D26DQ52663558-12F41963-E47D-44EA-A43B-39B4455FB50EQ58915024-6905C707-0389-4ACB-BAD0-8C19D8AB4663
P2860
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Blockade of the angiotensin II ...... ix metalloproteinase activity.
@en
Blockade of the angiotensin II ...... ix metalloproteinase activity.
@nl
type
label
Blockade of the angiotensin II ...... ix metalloproteinase activity.
@en
Blockade of the angiotensin II ...... ix metalloproteinase activity.
@nl
prefLabel
Blockade of the angiotensin II ...... ix metalloproteinase activity.
@en
Blockade of the angiotensin II ...... ix metalloproteinase activity.
@nl
P2093
P1433
P1476
Blockade of the angiotensin II ...... ix metalloproteinase activity.
@en
P2093
Andrea Mezzetti
Annalisa Iezzi
Barbara Pini
Chiara Cuccurullo
Domenico de Cesare
Francesco Spigonardo
Franco Cuccurullo
Marco Bucci
Maria Fazia
Mariella De Luca
P304
P356
10.1161/01.CIR.0000121735.52471.AC
P407
P577
2004-03-22T00:00:00Z